Sun Pharmaceuticals Industries Ltd
NSE :SUNPHARMA BSE :524715 Sector : PharmaceuticalsBuy, Sell or Hold SUNPHARMA? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
08 Nov 1809.60 (1.04%) | 07 Nov 1790.95 (-2.00%) | 06 Nov 1827.45 (1.32%) | 05 Nov 1803.60 (-0.29%) | 04 Nov 1808.90 (-2.66%) | 01 Nov 1858.40 (0.51%) | 31 Oct 1848.90 (-0.17%) | 30 Oct 1852.10 (-1.04%) | 29 Oct 1871.60 (-1.64%) | 28 Oct 1902.90 (2.28%) | 25 Oct 1860.40 (0.62%) | 24 Oct 1848.90 (0.52%) | 23 Oct 1839.35 (-2.55%) | 22 Oct 1887.55 (-0.50%) | 21 Oct 1897.00 (-0.70%) | 18 Oct 1910.35 (1.10%) | 17 Oct 1889.55 (-0.47%) | 16 Oct 1898.50 (0.00%) | 15 Oct 1898.45 (-0.59%) | 14 Oct 1909.75 (0.41%) | 11 Oct 1901.95 (0.75%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Bearish
Medium Term Investors
Very Bearish
Long Term Investors
Bullish
Moving Averages
5 DMA
Bullish
1808.43
10 DMA
Bearish
1837.59
20 DMA
Bearish
1860.56
50 DMA
Bearish
1865.98
100 DMA
Bullish
1755.76
200 DMA
Bullish
1639.3
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On Nov 08, 2024 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 1843.55 | 1829.3 | 1816.23 | - | - |
R2 | 1829.3 | 1820.09 | 1814.02 | 1830.4 | - |
R1 | 1819.45 | 1814.41 | 1811.81 | 1821.65 | 1824.38 |
P | 1805.2 | 1805.2 | 1805.2 | 1806.3 | 1807.66 |
S1 | 1795.35 | 1795.99 | 1807.39 | 1797.55 | 1800.28 |
S2 | 1781.1 | 1790.31 | 1805.18 | 1782.2 | - |
S3 | 1771.25 | 1781.1 | 1802.97 | - | - |
Key Metrics
EPS
11.49
P/E
157.65
P/B
18.42
Dividend Yield
0.75%
Market Cap
4,34,184 Cr.
Face Value
1
Book Value
98.33
ROE
16.13%
EBITDA Growth
4,291.96 Cr.
Debt/Equity
0.08
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Sun Pharmaceuticals Industries Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | |
INCOME | 12486.02 | 12630.9 | 12588.84 | 13185.3 | 13645.39 |
PROFIT | 2375.51 | 2583.5 | 2750.84 | 2835.62 | 3040.16 |
EPS | 9.9 | 10.5 | 11.1 | 11.8 | 12.7 |
Sun Pharmaceuticals Industries Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | |
INCOME | 5202.75 | 5150.55 | 5758.02 | 4580.81 | 5214.01 |
PROFIT | 888.63 | 788.32 | 867.6 | 237.82 | 863.29 |
EPS | 3.7 | 3 | 3.6 | 1 | 3.6 |
Profit & Loss (Figures in Rs. Crores)
Sun Pharmaceuticals Industries Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 27825.18 | 29539.05 | 32473.22 | 27097.52 | 30524.51 | 33188.24 | 34995.53 | 39837.57 | 45207.11 | 49595.04 | |
PROFIT | 4581.78 | 5027.37 | 6932.28 | 2794.9 | 3661.85 | 3960.73 | 5728.26 | 6717.12 | 8604.93 | 9990.19 | |
EPS | 25.79 | 23.51 | 32.66 | 10.7 | 13.38 | 17.45 | 9.52 | 14.2 | 35.68 | 40.21 |
Sun Pharmaceuticals Industries Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 7921.92 | 8178.89 | 8366.9 | 9951.27 | 11825.95 | 13904.25 | 14487.76 | 16966.04 | 21379.36 | 20648.33 | |
PROFIT | -1560.14 | -1349.86 | -266.99 | 1114.26 | 1865.28 | 3017.87 | 906.04 | -1337.5 | 3356.39 | 3051.64 | |
EPS | 0 | 0 | 0 | 1.27 | 3.4 | 13.38 | 3.51 | -0.42 | 7.05 | 11.91 |
Balance Sheet (Figures in Rs. Crores)
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 239.93 | 239.93 | 239.93 | 239.93 | 239.93 | 239.93 | 239.93 | 239.93 | 240.66 | 207.12 |
Reserves Total | 63,426.82 | 55,755.45 | 47,771.29 | 46,222.85 | 45,024.52 | 41,169.13 | 38,074.18 | 36,399.74 | 32,741.15 | 25,382.59 |
Equity Application Money | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.67 | 48.38 |
Total Shareholders Funds | 63,666.75 | 55,995.38 | 48,011.22 | 46,462.78 | 45,264.45 | 41,409.06 | 38,314.11 | 36,639.67 | 32,982.48 | 25,638.09 |
Minority Interest | 3,439.22 | 3,320.09 | 3,054.89 | 3,017.05 | 3,860.24 | 3,313.54 | 3,884.16 | 3,790.86 | 4,085.25 | 2,851.19 |
Secured Loans | 0 | 0 | 0 | 7.83 | 257.49 | 109.47 | 114.35 | 780.45 | 284.23 | 339.99 |
Unsecured Loans | 3,273.67 | 6,885.87 | 1,290.3 | 3,860.75 | 8,057.39 | 10,404.89 | 10,270.92 | 9,051.32 | 8,212.53 | 8,656.12 |
Total Debt | 3,273.67 | 6,885.87 | 1,290.3 | 3,868.58 | 8,314.88 | 10,514.36 | 10,385.27 | 9,831.77 | 8,496.76 | 8,996.11 |
Other Liabilities | 914.46 | 930.14 | 1,019.64 | 1,098.63 | 1,334.28 | 1,004.7 | 462.71 | 1,341.82 | 2,105.51 | 2,718.68 |
Total Liabilities | 71,294.1 | 67,131.48 | 53,376.05 | 54,447.04 | 58,773.85 | 56,241.66 | 53,046.25 | 51,604.12 | 47,670 | 40,204.07 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 44,283.71 | 43,099.95 | 38,707.36 | 35,578.99 | 35,115.97 | 31,687.04 | 26,948.81 | 24,466.42 | 22,180.41 | 20,406.83 |
Less: Accumulated Depreciation | 21,072.33 | 19,034.51 | 16,042.2 | 14,026.01 | 12,269.06 | 9,850.5 | 8,096.16 | 6,791.25 | 6,308.16 | 7,724.36 |
Net Block | 23,211.38 | 24,065.44 | 22,665.16 | 21,552.98 | 22,846.91 | 21,836.54 | 18,852.65 | 17,675.17 | 15,872.25 | 12,682.47 |
Capital Work in Progress | 5,353.88 | 4,973.16 | 1,286.8 | 1,566.83 | 1,220.34 | 1,411.15 | 2,465.16 | 2,801.38 | 2,175.45 | 2,038.61 |
Investments | 15,025.77 | 14,824.34 | 12,848.59 | 9,612.45 | 10,143.11 | 7,902.53 | 7,142.87 | 1,191.88 | 1,829.88 | 2,716.3 |
Inventories | 9,868.29 | 10,513.05 | 8,925.13 | 8,997.02 | 7,874.99 | 7,885.98 | 6,880.69 | 6,832.81 | 6,422.54 | 5,667.99 |
Sundry Debtors | 11,249.37 | 11,438.51 | 10,484.59 | 9,061.4 | 9,421.24 | 8,884.2 | 7,815.28 | 7,202.61 | 6,775.66 | 5,106.13 |
Cash and Bank Balance | 10,520.68 | 5,770.29 | 5,033.35 | 6,445.51 | 6,487.55 | 7,275.6 | 9,929.38 | 15,140.84 | 13,181.65 | 10,998.04 |
Loans and Advances | 3,210.23 | 2,767.48 | 2,787.59 | 2,808.09 | 2,973.02 | 3,072.69 | 2,919.93 | 3,546.51 | 2,847.64 | 5,026.16 |
Total Current Assets | 34,848.57 | 30,489.33 | 27,230.66 | 27,312.02 | 26,756.8 | 27,118.47 | 27,545.28 | 32,722.77 | 29,227.49 | 26,798.32 |
Current Liabilities | 8,244.46 | 7,917.33 | 7,076.42 | 8,413.45 | 5,382.08 | 5,288.6 | 6,008.65 | 5,328.3 | 4,536.85 | 4,166.36 |
Provisions | 5,769.26 | 5,663.09 | 9,323.44 | 4,761.73 | 4,038.39 | 3,059.27 | 5,242.49 | 4,163.03 | 3,220.65 | 4,352.76 |
Total Current Liabilities & Provisions | 14,013.72 | 13,580.42 | 16,399.86 | 13,175.18 | 9,420.47 | 8,347.87 | 11,251.14 | 9,491.33 | 7,757.5 | 8,519.12 |
Net Current Assets | 20,834.85 | 16,908.91 | 10,830.8 | 14,136.84 | 17,336.33 | 18,770.6 | 16,294.14 | 23,231.44 | 21,469.99 | 18,279.2 |
Deferred Tax Assets | 6,077.63 | 5,695.31 | 4,431.17 | 4,712.19 | 4,141.5 | 3,441.01 | 3,095.5 | 2,994.37 | 3,560.31 | 2,245.84 |
Deferred Tax Liability | 2,129.04 | 2,208.08 | 1,613.45 | 1,200.26 | 1,024.35 | 990.42 | 907.13 | 816.34 | 514.09 | 494.2 |
Net Deferred Tax | 3,948.59 | 3,487.23 | 2,817.72 | 3,511.93 | 3,117.15 | 2,450.59 | 2,188.37 | 2,178.03 | 3,046.22 | 1,751.64 |
Other Assets | 2,919.63 | 2,872.4 | 2,926.98 | 4,066.01 | 4,110.01 | 3,870.25 | 6,103.06 | 4,526.22 | 3,276.21 | 2,735.85 |
Total Assets | 71,294.1 | 67,131.48 | 53,376.05 | 54,447.04 | 58,773.85 | 56,241.66 | 53,046.25 | 51,604.12 | 47,670 | 40,204.07 |
Contingent Liabilities | 5,172.73 | 4,361.77 | 3,773.19 | 4,714.13 | 5,075.52 | 5,290.4 | 7,430.51 | 7,345.51 | 4,162.26 | 3,538.68 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 239.93 | 239.93 | 239.93 | 239.93 | 239.93 | 239.93 | 239.93 | 239.93 | 240.66 | 207.12 |
Reserves Total | 23,454.47 | 23,508.43 | 24,348.02 | 26,698.54 | 24,156.29 | 22,603.68 | 22,082.68 | 20,772.54 | 21,649.37 | 22,530.77 |
Equity Application Money | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.67 | 48.38 |
Total Shareholders Funds | 23,694.4 | 23,748.36 | 24,587.95 | 26,938.47 | 24,396.22 | 22,843.61 | 22,322.61 | 21,012.47 | 21,890.7 | 22,786.27 |
Secured Loans | 0 | 0 | 0 | 5.41 | 6.18 | 9.73 | 10.82 | 30.63 | 2,939.46 | 281.63 |
Unsecured Loans | 11,226.91 | 7,790.82 | 5,074.04 | 7,352.71 | 6,399.7 | 6,426.91 | 6,873.19 | 6,015.98 | 2,889.38 | 6,529.05 |
Total Debt | 11,226.91 | 7,790.82 | 5,074.04 | 7,358.12 | 6,405.88 | 6,436.64 | 6,884.01 | 6,046.61 | 5,828.84 | 6,810.68 |
Other Liabilities | 1,722.96 | 1,105.45 | 1,016.38 | 1,342.13 | 1,553.68 | 176.19 | 346.09 | 1,133.51 | 1,825.62 | 2,436.88 |
Total Liabilities | 36,644.27 | 32,644.63 | 30,678.37 | 35,638.72 | 32,355.78 | 29,456.44 | 29,552.71 | 28,192.59 | 29,545.16 | 32,033.83 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 18,251.74 | 17,744.68 | 17,194.98 | 15,812.29 | 8,244.71 | 7,461.34 | 6,572.66 | 4,988.08 | 4,103.7 | 5,995.07 |
Less : Accumulated Depreciation | 10,515 | 9,033.01 | 7,482.2 | 6,143.5 | 3,015.97 | 2,482.92 | 1,928.09 | 949.45 | 529.08 | 2,809.8 |
Net Block | 7,736.74 | 8,711.67 | 9,712.78 | 9,668.79 | 5,228.74 | 4,978.42 | 4,644.57 | 4,038.63 | 3,574.62 | 3,185.27 |
Capital Work in Progress | 766.11 | 852.91 | 828.64 | 1,090.38 | 596.61 | 642.54 | 987.84 | 1,100.5 | 767.73 | 1,090.59 |
Investments | 12,429.97 | 12,613.24 | 15,548.87 | 15,537.2 | 17,361.72 | 17,904.11 | 18,355.26 | 19,333.3 | 22,371.69 | 25,876.16 |
Inventories | 3,423.62 | 3,989.19 | 3,403.74 | 3,423.42 | 2,633.67 | 2,792.62 | 2,135.64 | 2,308.28 | 2,132.15 | 2,189.25 |
Sundry Debtors | 8,834.16 | 7,125.02 | 4,245.16 | 6,585.24 | 6,168.13 | 5,031.47 | 5,271.44 | 2,714.7 | 1,997.81 | 1,802.82 |
Cash and Bank Balance | 338.39 | 421.28 | 534.96 | 360.98 | 654.78 | 340.77 | 155.27 | 170.28 | 169.11 | 416.46 |
Loans and Advances | 2,316.37 | 4,708 | 1,326.85 | 2,329.44 | 2,089.47 | 2,756.96 | 1,968.1 | 1,154.92 | 943.63 | 947.82 |
Total Current Assets | 14,912.54 | 16,243.49 | 9,510.71 | 12,699.08 | 11,546.05 | 10,921.82 | 9,530.45 | 6,348.18 | 5,242.7 | 5,356.35 |
Current Liabilities | 3,811.44 | 7,533.36 | 7,524.56 | 6,891.41 | 4,956.61 | 5,713.96 | 4,586.35 | 3,829.25 | 3,541.69 | 3,345.03 |
Provisions | 609.08 | 809.5 | 2,562.55 | 1,204.66 | 1,097.94 | 2,543.73 | 2,652.75 | 1,847.43 | 1,179.61 | 2,066.69 |
Total Current Liabilities & Provisions | 4,420.52 | 8,342.86 | 10,087.11 | 8,096.07 | 6,054.55 | 8,257.69 | 7,239.1 | 5,676.68 | 4,721.3 | 5,411.72 |
Net Current Assets | 10,492.02 | 7,900.63 | -576.4 | 4,603.01 | 5,491.5 | 2,664.13 | 2,291.35 | 671.5 | 521.4 | -55.37 |
Deferred Tax Assets | 1,826.56 | 1,982.84 | 1,389.47 | 1,969.4 | 1,704.22 | 1,427.47 | 751.7 | 751.7 | 751.7 | 389.31 |
Deferred Tax Liability | 832.04 | 950.45 | 1,065.43 | 631.95 | 564.51 | 675.77 | 0 | 2.64 | 0 | 389.31 |
Net Deferred Tax | 994.52 | 1,032.39 | 324.04 | 1,337.45 | 1,139.71 | 751.7 | 751.7 | 749.06 | 751.7 | 0 |
Other Assets | 4,224.91 | 1,533.79 | 4,840.44 | 3,401.89 | 2,537.5 | 2,515.54 | 2,521.99 | 2,299.6 | 1,558.02 | 1,937.18 |
Total Assets | 36,644.27 | 32,644.63 | 30,678.37 | 35,638.72 | 32,355.78 | 29,456.44 | 29,552.71 | 28,192.59 | 29,545.16 | 32,033.83 |
Contingent Liabilities | 941.73 | 1,087.4 | 1,031.72 | 3,083.04 | 3,439.72 | 3,639.13 | 5,708.85 | 5,636.8 | 2,584.82 | 2,016.32 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 11,087.89 |
Depreciation | 2,556.64 |
Interest (Net) | -784.44 |
Dividend Received | 99.14 |
Prov. and W/O (Net) | 227.61 |
P/L in Forex | -249.92 |
Others | -77.39 |
Total Adjustments (PBT and Ext... | 1,554.4 |
Operating Profit before Workin... | 12,642.29 |
Trade and 0ther Receivables | 352.89 |
Inventories | 598.81 |
Trade Payables | 249.72 |
Total Adjustments (OP before W... | 1,062.13 |
Cash Generated from/(used in) ... | 13,704.42 |
Direct Taxes Paid | -1,569.44 |
Total Adjustments(Cash Generat... | -1,569.44 |
Cash Flow before Extraordinary... | 12,134.98 |
Net Cash from Operating Activi... | 12,134.98 |
Purchased of Fixed Assets | -2,201.81 |
Sale of Fixed Assets | 30.84 |
Purchase of Investments | -29,004.45 |
Sale of Investments | 30,094.47 |
Interest Received | 613.2 |
Investment in Group Cos. | -86.59 |
Acquisition of Companies | -143.32 |
Net Cash used in Investing Act... | -762.9 |
Proceed from 0ther Long Term B... | 4,572.65 |
Of the Long Tem Borrowings | -7,962.58 |
Of Financial Liabilities | -123.1 |
Dividend Paid | -2,900.71 |
Interest Paid | -219.03 |
Net Cash used in Financing Act... | -6,710.16 |
Net Profit before Tax and Extr... | 3,449.65 |
Depreciation | 1,600.62 |
Interest (Net) | 387.65 |
Prov. and W/O (Net) | 161.1 |
P/L in Forex | -358.3 |
Total Adjustments (PBT and Ext... | 1,768.91 |
Operating Profit before Workin... | 5,218.56 |
Trade and 0ther Receivables | -1,477.14 |
Inventories | 565.57 |
Trade Payables | -413.63 |
Total Adjustments (OP before W... | -5,169.11 |
Cash Generated from/(used in) ... | 49.45 |
Direct Taxes Paid | -341.87 |
Total Adjustments(Cash Generat... | -341.87 |
Cash Flow before Extraordinary... | -292.42 |
Net Cash from Operating Activi... | -292.42 |
Purchased of Fixed Assets | -749.24 |
Sale of Fixed Assets | 14.72 |
Purchase of Investments | -2,816.96 |
Sale of Investments | 3,039.25 |
Interest Received | 267.36 |
Loans to Subsidiaires | -1.53 |
Acquisition of Companies | -16.51 |
Net Cash used in Investing Act... | -265.35 |
Proceed from 0ther Long Term B... | 3,453.94 |
Of the Long Tem Borrowings | -10.66 |
Of Financial Liabilities | -5.81 |
Dividend Paid | -2,898.17 |
Interest Paid | -65.35 |
Net Cash used in Financing Act... | 473.95 |
Company Details
Registered Office |
|
Address | Sun Pharma Advanced Res.Centre, Tandalja |
City | Vadodara |
State | Gujarat |
Pin Code | 390020 |
Tel. No. | 91-265-6615500 |
Fax. No. | 91-265-2354897 |
secretarial@sunpharma.com | |
Internet | http://www.sunpharma.com |
Registrars |
|
Address | Sun Pharma Advanced Res.Centre |
City | Vadodara |
State | Gujarat |
Pin Code | 390020 |
Tel. No. | 91-265-6615500 |
Fax. No. | 91-265-2354897 |
secretarial@sunpharma.com | |
Internet | http://www.sunpharma.com |
Management |
|
Name | Designation |
Dilip S Shanghvi | Chairman & Managing Director |
Sudhir V Valia | Non-Exec & Non-Independent Dir |
Gautam Doshi | Non-Exec. & Independent Dir. |
Pawan Goenka | Lead Independent Director |
Rama Bijapurkar | Independent Director |
Anoop Deshpande | Company Sec. & Compli. Officer |
Sanjay K Asher | Independent Director |
Rolf Hoffmann | Independent Director |
Aalok Shanghvi | Whole Time Director |